N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.

[1]  D. Meyerhoff,et al.  Magnetic resonance detects brainstem changes in chronic, active heavy drinkers , 2004, Psychiatry Research: Neuroimaging.

[2]  M. Weiner,et al.  Identification of the Epileptogenic Lobe in Neocortical Epilepsy with Proton MR Spectroscopic Imaging , 2004, Epilepsia.

[3]  N. Cashdollar,et al.  Identification of Abnormal Neuronal Metabolism Outside the Seizure Focus in Temporal Lobe Epilepsy , 2004, Epilepsia.

[4]  L L Chao,et al.  Effects of heavy drinking, binge drinking, and family history of alcoholism on regional brain metabolites. , 2004, Alcoholism, clinical and experimental research.

[5]  M. Weiner,et al.  Reduced Extrahippocampal NAA in Mesial Temporal Lobe Epilepsy , 2002, Epilepsia.

[6]  N. Schuff,et al.  Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus , 2002, Neurology.

[7]  N. Schuff,et al.  Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD , 2002, Neurology.

[8]  G B Matson,et al.  1H MRSI predicts surgical outcome in MRI-negative temporal lobe epilepsy , 2002, Neurology.

[9]  N. Schuff,et al.  MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer’s disease , 2001, Neurology.

[10]  D. Meyerhoff,et al.  Effects of abstinence on the brain: quantitative magnetic resonance imaging and magnetic resonance spectroscopic imaging in chronic alcohol abuse. , 2001, Alcoholism, clinical and experimental research.

[11]  D. Meyerhoff,et al.  Separate and interactive effects of cocaine and alcohol dependence on brain structures and metabolites: quantitative MRI and proton MR spectroscopic imaging , 2001, Addiction biology.

[12]  Norbert Schuff,et al.  Reanalysis of multislice 1H MRSI in amyotrophic lateral sclerosis , 2001 .

[13]  Alessandro Bertolino,et al.  The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia , 2001, Biological Psychiatry.

[14]  H. Chui,et al.  Dementia due to subcortical ischemic vascular disease. , 2001, Clinical cornerstone.

[15]  M W Weiner,et al.  Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease , 2000, Neurology.

[16]  P M Pattany,et al.  MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. , 2000, AJNR. American journal of neuroradiology.

[17]  P. Pattany,et al.  1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis , 1999, Journal of the Neurological Sciences.

[18]  C. A. Morgan,et al.  Neurotransmitter alterations in PTSD: catecholamines and serotonin. , 1999, Seminars in clinical neuropsychiatry.

[19]  D. Shungu,et al.  Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain. , 1999, Radiology.

[20]  T. Ng,et al.  1H-MRS evidence of neurodegeneration and excess glutamate glutamine in ALS medulla , 1999, Neurology.

[21]  M W Weiner,et al.  Effects of subcortical cerebral infarction on cortical glucose metabolism and cognitive function. , 1999, Archives of neurology.

[22]  D. Arnold,et al.  Biological markers in the diagnosis and treatment of ALS , 1999, Journal of the Neurological Sciences.

[23]  P. Boesiger,et al.  Quantitative 1H MRS in the evaluation of mesial temporal lobe epilepsy in vivo. , 1998, Magnetic resonance imaging.

[24]  C. Heimberg,et al.  Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect , 1998, Psychiatry Research: Neuroimaging.

[25]  C. Karson,et al.  In vivo proton magnetic resonance spectroscopy of the medial temporal lobes of subjects with combat‐related posttraumatic stress disorder , 1998, Magnetic resonance in medicine.

[26]  F Träber,et al.  Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. , 1998, Archives of neurology.

[27]  M W Weiner,et al.  Decreased N‐acetylaspartate in motor cortex and corticospinal tract in ALS , 1998, Neurology.

[28]  D. Arnold,et al.  Recovery of N‐acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy , 1998, Neuroreport.

[29]  C. Hanstock,et al.  Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy , 1998, Neurology.

[30]  G. Fein,et al.  Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease , 1997, Neurology.

[31]  P M Matthews,et al.  Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy , 1997, Neurology.

[32]  M. Stein,et al.  Hippocampal volume in women victimized by childhood sexual abuse , 1997, Psychological Medicine.

[33]  G. Fein,et al.  Reduced Hippocampal Volume and N‐Acetyl Aspartate in Posttraumatic Stress Disorder , 1997, Annals of the New York Academy of Sciences.

[34]  S. Topp,et al.  Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy , 1997, Neurology.

[35]  G. Fein,et al.  Temporal lobe epilepsy: bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging. , 1997, Radiology.

[36]  R. Bronen,et al.  Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse—a preliminary report , 1997, Biological Psychiatry.

[37]  R. Kikinis,et al.  Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder , 1996, Biological Psychiatry.

[38]  R. Kuzniecky,et al.  Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging , 1996, Annals of neurology.

[39]  M. Giroud,et al.  Reduced brain N-acetyl-aspartate in frontal lobes suggests neuronal loss in patients with amyotrophic lateral sclerosis. , 1996, Neurological research.

[40]  G. Fein,et al.  Deep gray matter structures in HIV infection: a proton MR spectroscopic study. , 1996, AJNR. American journal of neuroradiology.

[41]  H. Soininen,et al.  Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia , 1996, Neurology.

[42]  P. Matthews,et al.  Reversible decreases in N‐acetylaspartate after acute brain injury , 1995, Magnetic resonance in medicine.

[43]  S. Southwick,et al.  MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. , 1995, The American journal of psychiatry.

[44]  S. Southwick,et al.  Relationships Between Thyroid Hormones and Symptoms in Combat-Related Posttraumatic Stress Disorder , 1995, Psychosomatic medicine.

[45]  G Scarlato,et al.  Central nervous system trans‐synaptic effects of acute axonal injury: a 1h magnetic resonance spectroscopy study , 1995, Magnetic resonance in medicine.

[46]  Andrew P Jones,et al.  Preliminary results of proton magnetic resonance spectroscopy in motor neurone disease (amytrophic lateral sclerosis) , 1995, Journal of the Neurological Sciences.

[47]  D. Arnold,et al.  Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo , 1994, Neurology.

[48]  J W Mason,et al.  Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. , 1993, The American journal of psychiatry.

[49]  J. Baron,et al.  Effects of thalamic stroke on energy metabolism of the cerebral cortex. A positron tomography study in man. , 1986, Brain : a journal of neurology.

[50]  A. Escobar.  Cerebral changes associated with senility. I. The role of transneuronal degeneration in the neocortex. , 1973, Boletin de estudios medicos y biologicos.